Michael King leads journal on nanotechnology in medicine

Michael King leads journal on nanotechnology in medicine. Michael R. King, associate professor of biomedical engineering, is editor-in-chief of the first scientific journal focused on nanotubes, nanorods and nanowires applied to medicine and biology. The online, peer-reviewed journal Nanotube Therapy launched in March through the open-access publisher Versita. The journal publishes papers on the chemistry, biology and engineering involved in the application of nanotube technology for the improvement of human health. Material properties, novel devices and clinical studies are all within the scope of the journal. Manuscripts using nanotubes for targeted drug delivery, biomaterials, imaging contrast agents and point-of-care diagnostic assays are encouraged. Of particular interest is research of a pre-clinical or translational nature that will have a clear impact on the diagnosis and treatment of human disease.